与患者及公众共享试验结果的指南范围综述:建议不一致且方法学开发有限
该范围综述系统检索并主题分析现有关于与患者和/或公众共享研究结果的指南类文献,共筛选2289条记录,纳入24篇文档,其中仅9篇广泛适用于临床试验设计。未发现专门针对随机试验结果共享的指南或报告规范,现有建议在内容、呈现、时间线和传播方式上质量与特异性不一,且多数缺少针对多元受众的定制化信息、文化敏感性和包容性考量。
要点
- 现有共享研究结果指南建议不一致,缺乏专门针对随机试验的报告规范。
- 多数指南未详述针对多元受众的信息定制,文化敏感性和包容性关注不足。
- 仅5篇文档在实施前经过试点测试,13篇报告了利益相关者参与但常不一致。
核心结论
- 现有共享研究结果指南缺乏标准化方法,未充分处理多样性考量且未经正式评估。
- 未来应遵循既定方法学共同生产定制化报告规范,纳入有意义的利益相关者参与和试点测试。
研究设计与样本
- 范围综述,系统检索Ovid MEDLINE®和Web of Science核心合集,并在PubMed®进行引文追踪,同时广泛检索灰色文献。
- 纳入英文文献,类型为提供与患者和/或公众共享研究结果指导或建议的期刊或灰色文献文档,发表时间不限。
- 共筛选2289条可能合格的记录,24篇文档符合纳入标准并被纳入综述。
主要发现
- 纳入的24篇文档中仅9篇广泛适用于临床试验设计。
- 未识别出专门针对与患者和公众共享随机试验结果的特定指南或报告规范。
- 关于内容、呈现、时间线和传播的建议在质量和特异性上存在差异。
- 多数指南文档缺乏针对多元受众定制信息的细节,对文化敏感性或包容性的关注极少。
- 仅5篇文档在实施前经过试点测试,13篇报告了利益相关者参与但通常不一致。
临床怎么用
- 研究人员在与患者和公众共享试验结果时,需注意现有指南建议不一致且缺乏随机试验专用规范。
- 共享信息时应关注多元受众的定制化需求,并考虑文化敏感性和包容性。
- 开发或选择共享结果指南时,应重视利益相关者参与和试点测试。
局限性
- 仅纳入英文文献,可能遗漏非英语指南。
- 纳入文档数量有限(24篇),且仅9篇广泛适用于临床试验设计。
- 多数纳入指南缺乏试点测试和正式评估,证据质量有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To identify, analyze and summarize existing guidance on sharing trial results with patients and the public and to provide recommendations for developing a high-quality reporting guideline that is user-friendly, effective, and accessible. STUDY DESIGN AND SETTING: We included English-language documents providing guidance or recommendations on sharing research study results with patients and/or the public, published anytime, in journals or gray literature. We systematically searched Ovid MEDLINE® and Web of Science Core Collection, performed citation tracking in PubMed®, and conducted extensive gray literature searches, including Google and Google Scholar, and other key websites (eg, EQUATOR Network, government and research organizations, publishing groups, research and policy centers). Titles and abstracts were screened for eligibility, followed by full-text review. The results were thematically analyzed. RESULTS: A total of 2289 potentially eligible records were screened, and 24 met eligibility criteria and included in the review. Of these, only 9 were broadly applicable to clinical trial designs. No specific guidance or reporting guideline was identified focusing on sharing results of randomized trials with patients and the public. Recommendations on content, presentation, timelines, and dissemination varied in quality and specificity. Most guidance documents lacked details on tailoring information for diverse audiences, with minimal focus on cultural sensitivity or inclusivity. Only five of the documents had been pilot-tested prior to implementation, and stakeholder involvement was reported in 13, though often inconsistently. CONCLUSION: Althougb there has been progress in developing guidance for sharing research results, many existing documents lack a standardized approach, do not sufficiently address diversity considerations and have not undergone formal evaluation. Future efforts should focus on coproducing a tailored reporting guideline following established methodology with meaningful stakeholder-involvement and pilot-testing to ensure that recommendations meet the diverse needs of patients and the public. PLAIN LANGUAGE SUMMARY: Sharing results in a clear, respectful way is an important part of doing good research. Evidence suggests that people who take part in research are routinely not told what the study found. However, there is little guidance available for researchers on how to do this in a meaningful way. In this review, we looked for any existing guidance on how to share research results with patients, and the public. We looked for both published and unpublished guidance documents. We found 24 documents, some of them had useful suggestions, but many were hard to find, vague, or missing important details. Many of them did not include input from patients or the public. None were made specifically for sharing results from randomized trials. Although there is some guidance available, there are still significant gaps. Our findings show that researchers need better and clearer guidance on how to share trial results. This would help make the information easier to understand, more inclusive, and more helpful for both patients and the public.
引用
- Choudhury S, Collins GS, Albury C, et al. A scoping review of guidance on sharing trial results with patients and the public finds inconsistent recommendations and limited methodological development. J Clin Epidemiol. 2026. PMID: 42361930. doi:10.1016/j.jclinepi.2026.112394
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。